Comparative Study of Hypo-Fractionated Radiotherapy Versus Conventional Radiotherapy in Breast Cancer.
breast cancer radiotherapy
conventional radiotherapy
hypofractionation
lumpectomy
mastectomy
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
16
08
2022
accepted:
13
09
2022
entrez:
19
10
2022
pubmed:
20
10
2022
medline:
20
10
2022
Statut:
epublish
Résumé
Breast cancer is the most commonly diagnosed cancer causing death among females worldwide. Radiotherapy after lumpectomy/mastectomy in breast cancer cases is a successful treatment modality taking five weeks to complete. The aim of the present study is to compare the effectiveness of hypo-fractionated radiotherapy in breast cancer patients with conventional radiotherapy with respect to outcome and toxicity. Sixty patients were randomly divided equally into a conventional group, Group A (dose: 50 Gy in 25 fractions), and a hypo-fractionated short-course radiotherapy group, Group B (dose: 40 Gy in 16 fractions). After thorough clinical and laboratory examination of all patients, the disease status was assessed prior to radiotherapy and three and six months after completion of radiotherapy. The cardiopulmonary function was assessed using echocardiography and pulmonary function tests prior to the procedure. The assessment of the development of toxicity (dysphagia, skin, lung, and lymphedema) was done during every clinical visit. The mean age of patients was 53.28 ± 9.73 years in Group A, and 55.67 ± 10.41 years in Group B (p=0.82). The right breast was involved in 13 (43.4%) patients in Group A and 14 (46.6%) in Group B, and the left breast was involved n 17 (56.6%) patients in Group A and 16 (53.4%) in Group B (p=0.81). Most of the patients were post-menopausal; 24 (80%) in Group A and 25 (83.4%) in Group B (p=0.91). Eleven (36.6%) patients were of stage T2N1M0 in both groups. However, no statistical difference was observed between the groups in the TNM (tumor, node, and metastasis) staging using the AJCC (American Joint Committee on Cancer) criteria (p=0.26). On comparing the responses in Group A and Group B, no significant difference was observed in either of the groups from immediate post-treatment to the 12-month follow-up period (p=0.53 and p=0.64, respectively). Hypo-fractionated radiotherapy is as effective as conventional radiotherapy and can be used as an alternative method for treatment following breast cancer surgery.
Sections du résumé
BACKGROUND
BACKGROUND
Breast cancer is the most commonly diagnosed cancer causing death among females worldwide. Radiotherapy after lumpectomy/mastectomy in breast cancer cases is a successful treatment modality taking five weeks to complete. The aim of the present study is to compare the effectiveness of hypo-fractionated radiotherapy in breast cancer patients with conventional radiotherapy with respect to outcome and toxicity.
METHODS
METHODS
Sixty patients were randomly divided equally into a conventional group, Group A (dose: 50 Gy in 25 fractions), and a hypo-fractionated short-course radiotherapy group, Group B (dose: 40 Gy in 16 fractions). After thorough clinical and laboratory examination of all patients, the disease status was assessed prior to radiotherapy and three and six months after completion of radiotherapy. The cardiopulmonary function was assessed using echocardiography and pulmonary function tests prior to the procedure. The assessment of the development of toxicity (dysphagia, skin, lung, and lymphedema) was done during every clinical visit.
RESULTS
RESULTS
The mean age of patients was 53.28 ± 9.73 years in Group A, and 55.67 ± 10.41 years in Group B (p=0.82). The right breast was involved in 13 (43.4%) patients in Group A and 14 (46.6%) in Group B, and the left breast was involved n 17 (56.6%) patients in Group A and 16 (53.4%) in Group B (p=0.81). Most of the patients were post-menopausal; 24 (80%) in Group A and 25 (83.4%) in Group B (p=0.91). Eleven (36.6%) patients were of stage T2N1M0 in both groups. However, no statistical difference was observed between the groups in the TNM (tumor, node, and metastasis) staging using the AJCC (American Joint Committee on Cancer) criteria (p=0.26). On comparing the responses in Group A and Group B, no significant difference was observed in either of the groups from immediate post-treatment to the 12-month follow-up period (p=0.53 and p=0.64, respectively).
CONCLUSION
CONCLUSIONS
Hypo-fractionated radiotherapy is as effective as conventional radiotherapy and can be used as an alternative method for treatment following breast cancer surgery.
Identifiants
pubmed: 36259037
doi: 10.7759/cureus.29147
pmc: PMC9562256
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e29147Informations de copyright
Copyright © 2022, Narwariya et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
World J Clin Oncol. 2022 Mar 24;13(3):209-218
pubmed: 35433294
Breast Cancer Res Treat. 2015 Apr;150(3):547-57
pubmed: 25820592
Radiother Oncol. 2005 Apr;75(1):9-17
pubmed: 15878095
N Engl J Med. 2010 Feb 11;362(6):513-20
pubmed: 20147717
Radiat Oncol J. 2016 Jun;34(2):81-7
pubmed: 27306774
Radiat Oncol. 2016 Apr 07;11:54
pubmed: 27056179
Breast Cancer Res Treat. 2017 Aug;165(1):193-200
pubmed: 28578505
Am J Cardiol. 2011 Feb 1;107(3):472-7
pubmed: 21257017
Indian J Med Res. 2012 Aug;136(2):205-10
pubmed: 22960886
JAMA. 2015 Oct 20;314(15):1599-614
pubmed: 26501536
Br J Cancer. 1987 Jan;55(1):61-6
pubmed: 3814476
J Mammary Gland Biol Neoplasia. 2000 Apr;5(2):139-63
pubmed: 11149570
Eur Heart J Cardiovasc Imaging. 2013 Aug;14(8):721-40
pubmed: 23847385